Use access key #2 to skip to page content.
$41.63 0.10 (0.24%)
11/21/2008 9:57 AM

Gilead Sciences, Inc. (GILD)

CAPS Rating:
****

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

View All Commentary (GILD)

Recs

0

Avatar bclan13 (99.42) Submitted: 3/23/08 10:45 PM : Outperform Start Price: $48.00 GILD Score: 23.65

I do not claim expertise on gilead,but I like big biotech at this point in the macroeconomic cycle and because of the barriers to entry for biotech drugs (difficult for generics to be manufactured).

I like genzyme and genentech more, bit gilead is a buy.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links